Understanding HPLC Testing

HPLC pushes a mobile phase through a packed column. Compounds in the sample interact differently with the stationary phase and so elute at different times. UV-Vis detection (usually 214 nm for peptide bonds) records each compound as a peak.

Reverse-phase C18 with a water/acetonitrile gradient is standard for peptide purity.

One dominant peak with minor shoulders is normal. Purity is the main peak area as a percentage of total area. Watch for unresolved shoulders that could indicate a deletion sequence or oxidation product.

HPLC purity is not a property of the peptide alone — it is a property of the peptide in a specific method. Column chemistry (C18 being the workhorse, with alternative phases for difficult sequences), mobile-phase pH and gradient steepness all change how co-eluting species separate. A sequence that reads 99.1% on one column can read 98.4% on another without either being wrong.

Detection wavelength matters too: 214 nm is standard for peptide bonds, but sequences with aromatic residues absorb strongly at 280 nm, and minor impurities can hide or reveal themselves depending on the wavelength used. This is why serious reports state their method parameters, and why cross-comparing purity numbers between suppliers requires knowing both methods — not just both percentages.

Integration is where analysis meets judgement. The software proposes peak boundaries; the analyst confirms or corrects them, decides how to treat shoulders and solvent fronts, and chooses whether an unidentified minor peak is a real impurity or an artefact. Two competent analysts can produce slightly different numbers from the same raw trace — which is normal, and why a single percentage should be read as a well-supported estimate rather than an absolute.

The practical takeaway for researchers: a report that shows the full chromatogram lets you see the basis for the number, while a bare percentage asks you to trust it. The chromatogram is the evidence; the percentage is the headline.